pubmed-article:18028519 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18028519 | lifeskim:mentions | umls-concept:C0019682 | lld:lifeskim |
pubmed-article:18028519 | lifeskim:mentions | umls-concept:C0556025 | lld:lifeskim |
pubmed-article:18028519 | lifeskim:mentions | umls-concept:C0242456 | lld:lifeskim |
pubmed-article:18028519 | lifeskim:mentions | umls-concept:C0042658 | lld:lifeskim |
pubmed-article:18028519 | lifeskim:mentions | umls-concept:C0679771 | lld:lifeskim |
pubmed-article:18028519 | lifeskim:mentions | umls-concept:C0199176 | lld:lifeskim |
pubmed-article:18028519 | lifeskim:mentions | umls-concept:C0014406 | lld:lifeskim |
pubmed-article:18028519 | lifeskim:mentions | umls-concept:C0728831 | lld:lifeskim |
pubmed-article:18028519 | lifeskim:mentions | umls-concept:C0008115 | lld:lifeskim |
pubmed-article:18028519 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:18028519 | pubmed:dateCreated | 2007-12-17 | lld:pubmed |
pubmed-article:18028519 | pubmed:abstractText | This paper reviews the evolution of government policies in China and Vietnam regarding harm reduction interventions for human immunodeficiency virus (HIV) prevention, such as needle/syringe provision and opioid substitution treatment. | lld:pubmed |
pubmed-article:18028519 | pubmed:language | eng | lld:pubmed |
pubmed-article:18028519 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18028519 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18028519 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18028519 | pubmed:month | Jan | lld:pubmed |
pubmed-article:18028519 | pubmed:issn | 0965-2140 | lld:pubmed |
pubmed-article:18028519 | pubmed:author | pubmed-author:FengZ LZL | lld:pubmed |
pubmed-article:18028519 | pubmed:author | pubmed-author:FeyzB BBB | lld:pubmed |
pubmed-article:18028519 | pubmed:author | pubmed-author:TomP APA | lld:pubmed |
pubmed-article:18028519 | pubmed:author | pubmed-author:Des... | lld:pubmed |
pubmed-article:18028519 | pubmed:author | pubmed-author:StephensDavid... | lld:pubmed |
pubmed-article:18028519 | pubmed:author | pubmed-author:WuZunyouZ | lld:pubmed |
pubmed-article:18028519 | pubmed:author | pubmed-author:HammettTheodo... | lld:pubmed |
pubmed-article:18028519 | pubmed:author | pubmed-author:DucTran... | lld:pubmed |
pubmed-article:18028519 | pubmed:author | pubmed-author:SullivanSheen... | lld:pubmed |
pubmed-article:18028519 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:18028519 | pubmed:volume | 103 | lld:pubmed |
pubmed-article:18028519 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18028519 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18028519 | pubmed:pagination | 137-45 | lld:pubmed |
pubmed-article:18028519 | pubmed:meshHeading | pubmed-meshheading:18028519... | lld:pubmed |
pubmed-article:18028519 | pubmed:meshHeading | pubmed-meshheading:18028519... | lld:pubmed |
pubmed-article:18028519 | pubmed:meshHeading | pubmed-meshheading:18028519... | lld:pubmed |
pubmed-article:18028519 | pubmed:meshHeading | pubmed-meshheading:18028519... | lld:pubmed |
pubmed-article:18028519 | pubmed:meshHeading | pubmed-meshheading:18028519... | lld:pubmed |
pubmed-article:18028519 | pubmed:meshHeading | pubmed-meshheading:18028519... | lld:pubmed |
pubmed-article:18028519 | pubmed:meshHeading | pubmed-meshheading:18028519... | lld:pubmed |
pubmed-article:18028519 | pubmed:meshHeading | pubmed-meshheading:18028519... | lld:pubmed |
pubmed-article:18028519 | pubmed:meshHeading | pubmed-meshheading:18028519... | lld:pubmed |
pubmed-article:18028519 | pubmed:meshHeading | pubmed-meshheading:18028519... | lld:pubmed |
pubmed-article:18028519 | pubmed:meshHeading | pubmed-meshheading:18028519... | lld:pubmed |
pubmed-article:18028519 | pubmed:meshHeading | pubmed-meshheading:18028519... | lld:pubmed |
pubmed-article:18028519 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:18028519 | pubmed:articleTitle | 'Social evils' and harm reduction: the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam. | lld:pubmed |
pubmed-article:18028519 | pubmed:affiliation | Abt Associates Inc., Cambridge, MA 02138-1168, USA. ted_hammett@abtassoc.com | lld:pubmed |
pubmed-article:18028519 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:18028519 | pubmed:publicationType | Review | lld:pubmed |
pubmed-article:18028519 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18028519 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18028519 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18028519 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18028519 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18028519 | lld:pubmed |